Cargando…
Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients?
OBJECTIVES: This study aims to investigate the use of multiple blood management strategies and the effect of tourniquet on the estimated blood loss (EBL) in Jehovah's Witness (JW) patients who underwent primary total knee arthroplasty (TKA). PATIENTS AND METHODS: Twenty-two self-reported JW pat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bayçınar Medical Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607954/ https://www.ncbi.nlm.nih.gov/pubmed/32962570 http://dx.doi.org/10.5606/ehc.2020.76244 |
_version_ | 1783604744303935488 |
---|---|
author | Levent, Ali Köse, Özkan Linke, Philip Gehrke, Thorsten Çıtak, Mustafa |
author_facet | Levent, Ali Köse, Özkan Linke, Philip Gehrke, Thorsten Çıtak, Mustafa |
author_sort | Levent, Ali |
collection | PubMed |
description | OBJECTIVES: This study aims to investigate the use of multiple blood management strategies and the effect of tourniquet on the estimated blood loss (EBL) in Jehovah's Witness (JW) patients who underwent primary total knee arthroplasty (TKA). PATIENTS AND METHODS: Twenty-two self-reported JW patients (9 males, 13 females; mean age 66.8±8.6 years; range, 51 to 83 years) who underwent primary TKA between January 2014 and January 2020 in our institution were retrospectively reviewed. A standard blood management protocol that consisted of hypotensive anesthesia, local and systemic administration of tranexamic acid (TXA) and intraoperative cell salvage was applied to all patients. Patients were divided into two groups: with (n=11) and without (n=11) tourniquet use. The EBL was calculated according to Meunier’s formula. Hemoglobin (Hgb), hematocrit (Hct), and EBL on the first and third postoperative days were compared statistically. RESULTS: There was no significant difference between groups regarding postoperative Hgb (p=0.801 and p=0.767), Hct (p=0.617 and p=0.895), Hgb decline (p=0.311 and p=0.822), and EBL (p=0.067 and p=0.284) at first and third postoperative days. None of the patients required blood transfusion. No wound complication or symptomatic deep vein thrombosis was seen during the hospital stay. CONCLUSION: Combined use of hypotensive anesthesia, intravenous administration of TXA, intraoperative periarticular injection, and cell salvage seem to be sufficient in controlling the blood loss in JW patients during TKA. Additional tourniquet use may not further decrease the EBL. |
format | Online Article Text |
id | pubmed-7607954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Bayçınar Medical Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-76079542020-11-04 Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? Levent, Ali Köse, Özkan Linke, Philip Gehrke, Thorsten Çıtak, Mustafa Jt Dis Relat Surg Original Article OBJECTIVES: This study aims to investigate the use of multiple blood management strategies and the effect of tourniquet on the estimated blood loss (EBL) in Jehovah's Witness (JW) patients who underwent primary total knee arthroplasty (TKA). PATIENTS AND METHODS: Twenty-two self-reported JW patients (9 males, 13 females; mean age 66.8±8.6 years; range, 51 to 83 years) who underwent primary TKA between January 2014 and January 2020 in our institution were retrospectively reviewed. A standard blood management protocol that consisted of hypotensive anesthesia, local and systemic administration of tranexamic acid (TXA) and intraoperative cell salvage was applied to all patients. Patients were divided into two groups: with (n=11) and without (n=11) tourniquet use. The EBL was calculated according to Meunier’s formula. Hemoglobin (Hgb), hematocrit (Hct), and EBL on the first and third postoperative days were compared statistically. RESULTS: There was no significant difference between groups regarding postoperative Hgb (p=0.801 and p=0.767), Hct (p=0.617 and p=0.895), Hgb decline (p=0.311 and p=0.822), and EBL (p=0.067 and p=0.284) at first and third postoperative days. None of the patients required blood transfusion. No wound complication or symptomatic deep vein thrombosis was seen during the hospital stay. CONCLUSION: Combined use of hypotensive anesthesia, intravenous administration of TXA, intraoperative periarticular injection, and cell salvage seem to be sufficient in controlling the blood loss in JW patients during TKA. Additional tourniquet use may not further decrease the EBL. Bayçınar Medical Publishing 2020-07-16 /pmc/articles/PMC7607954/ /pubmed/32962570 http://dx.doi.org/10.5606/ehc.2020.76244 Text en Copyright © 2020, Turkish Joint Diseases Foundation http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Article Levent, Ali Köse, Özkan Linke, Philip Gehrke, Thorsten Çıtak, Mustafa Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? |
title | Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? |
title_full | Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? |
title_fullStr | Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? |
title_full_unstemmed | Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? |
title_short | Does tourniquet use decrease blood loss following primary total knee arthroplasty in Jehovah’s Witness patients? |
title_sort | does tourniquet use decrease blood loss following primary total knee arthroplasty in jehovah’s witness patients? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607954/ https://www.ncbi.nlm.nih.gov/pubmed/32962570 http://dx.doi.org/10.5606/ehc.2020.76244 |
work_keys_str_mv | AT leventali doestourniquetusedecreasebloodlossfollowingprimarytotalkneearthroplastyinjehovahswitnesspatients AT koseozkan doestourniquetusedecreasebloodlossfollowingprimarytotalkneearthroplastyinjehovahswitnesspatients AT linkephilip doestourniquetusedecreasebloodlossfollowingprimarytotalkneearthroplastyinjehovahswitnesspatients AT gehrkethorsten doestourniquetusedecreasebloodlossfollowingprimarytotalkneearthroplastyinjehovahswitnesspatients AT cıtakmustafa doestourniquetusedecreasebloodlossfollowingprimarytotalkneearthroplastyinjehovahswitnesspatients |